ストックスクリーナーアプリを入手
1.71
7.57%
-0.14
アフターアワーズ：
1.75
0.04
+2.34%
前日終値:
$1.85
開ける：
$1.82
24時間の取引高:
96,640
Relative Volume:
0.30
時価総額：
$5.00M
収益：
-
当期純損益:
$-4.21M
株価収益率:
-31.20
EPS:
-0.0548
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-9.04%
1か月 パフォーマンス:
-27.54%
6か月 パフォーマンス:
-93.56%
1年 パフォーマンス:
-99.40%
1日の値動き範囲:
$1.70
$1.8399
1週間の範囲:
$1.70
$1.90
52週間の値動き範囲:
$1.70
$306.00
Conduit Pharmaceuticals Inc Stock (CDT) Company Profile
名前
Conduit Pharmaceuticals Inc
セクター
電話
(646) 491 9132
住所
4851 TAMIAMI TRAIL NORTH, NAPLES
CDT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CDT
Conduit Pharmaceuticals Inc
|
1.71 | 5.44M | 0 | -4.21M | 0 | -0.0548 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.46 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.94 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
435.00 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
638.90 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
289.75 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Conduit Pharmaceuticals Inc (CDT) 最新ニュース
Key metrics from Conduit Pharmaceuticals Inc. Equity Warrant’s quarterly dataFree Chart Breakout Buy Signal Detection - Newser
Statistical indicators supporting Conduit Pharmaceuticals Inc.’s strengthSwing Trade Entry and Exit Point Analysis - Newser
What candlestick patterns are forming on Conduit Pharmaceuticals Inc. Equity WarrantRapid Trade Forecast Based on Indicators - Newser
Does Conduit Pharmaceuticals Inc. fit your quant trading modelSummary of Reliable Long-Term Trade Models - Newser
How to monitor Conduit Pharmaceuticals Inc. with trend dashboardsLong-Term Investment Strategy Summary Guide - Newser
Is it time to cut losses on Conduit Pharmaceuticals Inc.Equity Portfolio Outlook and Performance Summary - Newser
Can volume confirm reversal in Conduit Pharmaceuticals Inc.Free Short Term High Yield Stock Tips - Newser
Will breakout in Conduit Pharmaceuticals Inc. Equity Warrant lead to full recoveryAutomated AI Forecast with Trading Alerts - Newser
How Conduit Pharmaceuticals Inc. Equity Warrant stock performs during market volatilityHigh Win Rate Strategy with Stop Protection - Newser
Real time scanner hits for Conduit Pharmaceuticals Inc. Equity Warrant explainedRisk-Managed Swing Setup and Signal Analysis - Newser
What momentum shifts mean for Conduit Pharmaceuticals Inc. Equity WarrantSector Rotation Outlook With Historical Summary - Newser
Intraday Charts Show Spike in Conduit Pharmaceuticals Inc. ActivityAI Forecast for Trending Stocks Indicates Upside - beatles.ru
How to use a screener to detect Conduit Pharmaceuticals Inc. breakoutsFree Triple Digit Growth Focused Trade Plan - Newser
Published on: 2025-08-09 04:41:32 - Newser
Published on: 2025-08-08 23:58:05 - Newser
Conduit Pharmaceuticals Rebrands to CDT Equity Inc. - TipRanks
Conduit Pharmaceuticals to rename as CDT Equity Inc. - AInvest
Will Conduit Pharmaceuticals Inc. Equity Warrant stock recover after recent dropFree AI Based High Gain Watchlist Scanner - Newser
Conduit to change name to CDT Equity - MSN
Published on: 2025-08-05 21:29:13 - Newser
Leading vs lagging indicators on Conduit Pharmaceuticals Inc. performanceMinimal Risk Growth Investment Opportunity Analysis - Newser
Conduit Pharmaceuticals Changes Name to CDT Equity Inc. - AInvest
CDT Equity Inc. Emerges as Biotech Development Company with Evolved Strategy - AInvest
Conduit to Change Name to CDT Equity Inc. - FinancialContent
Conduit Pharmaceuticals Inc. Equity Warrant stock chart pattern explainedFree Risk Controlled Short Term Trade Plans - Newser
Price Consolidation Hints at Upcoming Move in Conduit Pharmaceuticals Inc.Step-by-Step Stock Investment Guide Gains Popularity - beatles.ru
How does Conduit Pharmaceuticals Inc. Equity Warrant generate profit in a changing economyMaster stock selection with insider knowledge - Jammu Links News
Is Conduit Pharmaceuticals Inc. Equity Warrant a growth stock or a value stockUnlock the power of real-time market data - Jammu Links News
What is the dividend policy of Conduit Pharmaceuticals Inc. stockPhenomenal capital gains - Jammu Links News
What analysts say about Conduit Pharmaceuticals Inc. stockGet timely advice on market trends - Jammu Links News
What drives Conduit Pharmaceuticals Inc. stock priceUnlock exclusive trading strategies for gains - Jammu Links News
What is Conduit Pharmaceuticals Inc. Equity Warrant company’s growth strategyBuild wealth faster with disciplined trading - Jammu Links News
How many analysts rate Conduit Pharmaceuticals Inc. as a “Buy”Expert guidance for superior capital growth - Jammu Links News
When is Conduit Pharmaceuticals Inc. stock expected to show significant growthExplosive capital appreciation - Jammu Links News
Why is Conduit Pharmaceuticals Inc. stock attracting strong analyst attentionBuild wealth faster with high-performing stocks - Jammu Links News
Should I hold or sell Conduit Pharmaceuticals Inc. Equity Warrant stock in 2025Double-digit growth - Jammu Links News
Is it the right time to buy Conduit Pharmaceuticals Inc. stockAchieve rapid growth with smart investments - Jammu Links News
What makes Conduit Pharmaceuticals Inc. Equity Warrant stock price move sharplyGet real-time updates on market trends - Jammu Links News
Can technical indicators confirm Conduit Pharmaceuticals Inc. Equity Warrant’s reversalROI Focused Setup Screener With Exit Markers - Newser
How strong is Conduit Pharmaceuticals Inc. Equity Warrant company’s balance sheetUnlock powerful investment tools for free - Jammu Links News
Conduit Pharmaceuticals Inc. Equity Warrant Stock Analysis and ForecastBuild wealth faster with consistent investment plans - Jammu Links News
Published on: 2025-08-03 15:04:44 - Jammu Links News
How does Conduit Pharmaceuticals Inc. Equity Warrant compare to its industry peersMaximize gains with timely market signals - Jammu Links News
What drives Conduit Pharmaceuticals Inc. Equity Warrant stock priceAchieve rapid financial growth with expert picks - Jammu Links News
What catalysts could drive Conduit Pharmaceuticals Inc. Equity Warrant stock higher in 2025Maximize returns with timely market signals - Jammu Links News
How does Conduit Pharmaceuticals Inc. compare to its industry peersExponentially increasing returns - Jammu Links News
What is the risk reward ratio of investing in Conduit Pharmaceuticals Inc. stockOutstanding capital returns - Jammu Links News
Should I hold or sell Conduit Pharmaceuticals Inc. stock in 2025Unlock your portfolio’s full growth potential - Jammu Links News
How many analysts rate Conduit Pharmaceuticals Inc. Equity Warrant as a “Buy”Accelerated wealth expansion - Jammu Links News
What catalysts could drive Conduit Pharmaceuticals Inc. stock higher in 2025Free Smart Trading Workshop - Jammu Links News
What are Conduit Pharmaceuticals Inc. company’s key revenue driversRetirement Planning Tips With Low Risk - Jammu Links News
Conduit Pharmaceuticals Inc (CDT) 財務データ
収益
当期純利益
現金流量
EPS
Conduit Pharmaceuticals Inc (CDT) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Nirland Ltd | 10% Owner |
Oct 04 '24 |
Sale |
0.10 |
1,368,991 |
140,458 |
7,031,009 |
| Nirland Ltd | 10% Owner |
Oct 07 '24 |
Sale |
0.10 |
939,009 |
96,530 |
6,092,000 |
| Nirland Ltd | 10% Owner |
Oct 01 '24 |
Sale |
0.11 |
1,250,000 |
141,375 |
10,233,177 |
| Nirland Ltd | 10% Owner |
Sep 30 '24 |
Sale |
0.12 |
1,016,823 |
122,019 |
11,483,177 |
| Nirland Ltd | 10% Owner |
Oct 02 '24 |
Sale |
0.10 |
333,177 |
34,251 |
9,900,000 |
3.70%
1.02%
大文字化:
|
ボリューム (24 時間):